We are live on ! Find out more

478 hedge funds and large institutions have $4.98B invested in Genpact in 2026 Q2 according to their latest regulatory filings, with 72 funds opening new positions, 176 increasing their positions, 202 reducing their positions, and 107 closing their positions.

New
Increased
Maintained
Reduced
Closed

439% more call options, than puts

Call options by funds: $3.72M | Put options by funds: $690K

0.56% more ownership

Funds ownership: 105.5%106.05% (+0.56%)

8% less funds holding

Funds holding: 520478 (-42)

13% less repeat investments, than reductions

Existing positions increased: 176 | Existing positions reduced: 202

26% less capital invested

Capital invested by funds: $6.69B → $4.98B (-$1.71B)

33% less first-time investments, than exits

New positions opened: 72 | Existing positions closed: 107

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
478
Holders Change
-42
Holders Change %
-8.08%
% of All Funds
5.76%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
72
Increased
176
Reduced
202
Closed
107
Calls
$3.72M
Puts
$690K
Net Calls
+$3.03M
Net Calls Change
+$1.73M

G Hedge Fund Activity: Q2 2026 in Review

478 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Genpact (G) for Q2 2026, worth a combined $4.98B — down 26% from $6.69B a quarter earlier.

Sellers outnumbered buyers: 107 funds closed out of G and 72 opened new positions — a net loss of 35 holders — while 202 trimmed existing stakes and 176 added.

The largest buyer was Pzena Investment Management, adding an estimated $85M. The largest seller was Fidelity Investments, cutting an estimated $312M.

  • 478 institutional investors held Genpact (G) as of Q2 2026, down from 520 in Q1 2026.
  • Funds reported $4.98B of Genpact stock for Q2 2026, down 26% quarter-over-quarter.
  • 72 funds opened new Genpact positions in Q2 2026 and 107 closed out, a net change of -35 holders.
  • The largest Genpact buyer in Q2 2026 was Pzena Investment Management, an estimated $85M added.
  • The largest Genpact seller in Q2 2026 was Fidelity Investments, an estimated $312M sold.

Based on aggregated 13F filings for Q2 2026.